WHO Ebola Vaccine Trial in DRC

The World Health Organisation has initiated the first clinical trial of an Ebola vaccine in the Democratic Republic of Congo, targeting the Bundibugyo strain. The trial, named Tumaini, began with vaccinations in Bunia and will assess multiple vaccine candidates.

The World Health Organisation has initiated the first clinical trial of an Ebola vaccine in the Democratic Republic of the Congo, where over 4,600 deaths have occurred due to the outbreak. The trial aims to test the Ervebo vaccine against the Bundibugyo strain.

The Democratic Republic of the Congo has initiated a Phase 2/3 clinical trial to test vaccine candidates against the Bundibugyo virus, starting with the vaccination of the first participant in Bunia. This trial aims to address the ongoing outbreak.